| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.98▲ | 1.99▲ | 1.99▲ | 1.96▲ | 2.26▼ |
| MA10 | 1.98▲ | 1.97▲ | 1.96▲ | 2.00▼ | 2.07▼ |
| MA20 | 1.97▲ | 1.96▲ | 1.96▲ | 2.17▼ | 2.02▼ |
| MA50 | 1.95▲ | 1.97▲ | 2.00▲ | 2.01▼ | 1.61▲ |
| MA100 | 1.97▲ | 2.13▼ | 2.19▼ | 2.01▼ | 1.11▲ |
| MA200 | 2.20▼ | 2.26▼ | 2.07▼ | 1.81▲ | 1.44▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | 0.011▲ | 0.014▲ | -0.048▼ | -0.008▼ |
| RSI | 61.498▲ | 58.429▲ | 56.571▲ | 45.671▼ | 50.517▲ |
| STOCH | 50.000 | 88.796▲ | 86.667▲ | 16.593▼ | 74.513 |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -81.695▼ | -47.436 |
| CCI | 192.271▲ | 116.150▲ | 109.612▲ | -65.179 | 6.334 |
| MA | $INAB Price Crossed Above MA(7) | Set Alert |
|
Tuesday, February 03, 2026 05:16 AM
IO360° Conference Date: Thursday, February 12, 2026 Time: 1:20 p.m. – 1:40 p.m. ET Session: IO Clinical Advancements Plenary Presentation title: IN8bio’s Unique DeltEx Drug Resistant Immunotherapy ...
|
|
Monday, January 12, 2026 05:00 AM
Repeat-doses of DeltEx™ Drug-Resistant Immunotherapy gamma-delta (γδ) T cells (DRI) nearly doubled median progression-free survival (mPFS) to 13.0 months compared to only 6.6 months (+97%) in a ...
|
|
Friday, December 19, 2025 08:44 AM
(RTTNews) - IN8bio, Inc. (INAB), said on Friday, a biopharmaceutical company that's currently in clinical stages and working on T cell therapies for cancer and autoimmune diseases announced it had ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/02/26 | 1.90 | 2.03 | 1.85 | 1.99 | 36,804 |
| 05/02/26 | 1.96 | 1.96 | 1.88 | 1.90 | 73,878 |
| 04/02/26 | 2.02 | 2.14 | 1.95 | 1.96 | 29,977 |
| 03/02/26 | 1.96 | 2.09 | 1.95 | 1.99 | 61,132 |
| 02/02/26 | 1.93 | 2.00 | 1.88 | 1.96 | 49,038 |
| 30/01/26 | 1.97 | 2.03 | 1.87 | 1.97 | 36,330 |
| 29/01/26 | 1.96 | 2.05 | 1.91 | 2.00 | 63,152 |
| 28/01/26 | 2.09 | 2.17 | 1.96 | 1.96 | 66,458 |
| 27/01/26 | 2.18 | 2.255 | 2.05 | 2.07 | 57,415 |
| 26/01/26 | 2.33 | 2.40 | 2.20 | 2.20 | 85,917 |
|
|
||||
|
|
||||
|
|